Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Cash flow from operating activities:
Net loss	$ (12,664,388)	$ (13,983,967)
Loss from discontinued operations	(1,804,183)	(1,966,406)
Net loss from continuing operations	(10,860,205)	(12,017,561)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	162,079	244,788
Amortization of operating lease right-of-use assets	533,584	480,020
Vesting expense	1,118	1,167
Common stock issued for consulting and other	99,253	299,430
(Gain) on derivative instruments	(1,376)	(12,457)
Loss on disposal of property and equipment	803	903
Loss on disposal of intangible assets	4,738	0
Changes in assets and liabilities:
Accounts receivable	(467,925)	19,003
Inventories	95,075	(65,448)
Prepaid expense and other assets	208,776	(41,146)
Accounts payable	(191,145)	399,207
Accrued expenses and other	(134,961)	(384,149)
Contract liabilities	2,486	(266,803)
Operating lease liability	(444,896)	(446,483)
Other long-term liabilities	18,028	5,459
Net cash (used in) continuing operating activities:	(10,974,568)	(11,784,070)
Cash flow from continuing investing activities:
Purchase of property and equipment	(9,510)	(21,533)
Acquisition of intangibles	0	(26,017)
Net cash (used in) continuing investing activities:	(9,510)	(47,550)
Cash flow from continuing financing activities:
Proceeds from issuance of common stock and warrants	4,960,562	0
Costs to issue common stock and warrants	(870,960)	0
Repurchase of common stock upon vesting of restricted stock units	0	(1,509)
Proceeds from issuance of financing note payable	275,098	364,721
Repayment of note payable	(425,506)	(214,313)
Net cash provided by continuing financing activities	3,939,194	148,899
Discontinued operations:
Net cash (used in) operating activities	(981,103)	(1,405,321)
Net cash provided by (used in) investing activities	32,000	(254,821)
Net cash provided by (used in) financing activities	0	0
Net cash (used in) discontinued operations	(949,103)	(1,660,142)
Net (decrease) in cash	(7,993,987)	(13,342,863)
Cash and cash equivalents at beginning of period	8,728,660	22,071,523
Cash and cash equivalents at end of period	734,673	8,728,660
Supplemental disclosure for cash flow information:
Cash payments for interest	11,466	13,904
Equipment transferred from discontinued operations	5,140	0
Right-of-use assets obtained in exchange for lease liabilities	0	2,997,181
Series F Preferred Stock dividend	0	794
Common stock issued	0	189,896
Redemption of Series F Preferred Stock	0	794
Redemption of Series F Preferred Stock	0	(794)
Reverse Stock Split [Member]
Supplemental disclosure for cash flow information:
Common stock issued	0	253
Restricted Stock Units (RSUs) [Member]
Supplemental disclosure for cash flow information:
Common stock issued	$ 0	$ 4,934